Oculis Holding AG (FRA:CR5) Volatility: 81.51% (As of Jul. 02, 2026)


FRA:CR5 Oculis Holding AG FRA:CR5
22 GF Score
Price €11.55
! 1 Warning Sign
View Full Analysis

What is Oculis Holding AG Volatility?

Oculis Holding AG FRA:CR5 +5.00% 22 Volatility is 81.51% as of Jul. 02, 2026. GuruFocus rates FRA:CR5 with a GF Score™ of 22/100. The stock has 1 warning sign investors should review.

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2026-07-02), Oculis Holding AG's Volatility is 81.51%.

Oculis Holding AG  (FRA:CR5) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Oculis Holding AG Volatility Related Terms

FRA:CR5 vs NVCT, AURA, CADL: Volatility Comparison

For the Biotechnology subindustry, Oculis Holding AG's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oculis Holding AG Volatility vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oculis Holding AG's Volatility distribution charts can be found below:

* The bar in red indicates where Oculis Holding AG's Volatility falls into.


FRA:CR5
22GF Score
Oculis Holding AG FRA:CR5
Volatility is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oculis Holding AG  (FRA:CR5) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * √12
=√ 1/(n-1) ∑(Ri - R')^2 * √12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Volatility →
What does a Volatility of 81.51% mean?
Oculis Holding AG (FRA:CR5) has a Volatility of 81.51% as of Jul. 02, 2026. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Oculis Holding AG and its competitors.
Is Oculis Holding AG's Volatility too high?
Oculis Holding AG's current Volatility is 81.51%. Overall, Oculis Holding AG has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Oculis Holding AG's Volatility compare to NVCT and AURA?
Oculis Holding AG's Volatility of 81.51% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Volatility for a Biotechnology company?
A good Volatility depends on the Biotechnology industry context. However, Volatility should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Volatility mean?
A high Volatility can signal that a stock is expensive relative to its fundamentals. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Oculis Holding AG and its competitors. Oculis Holding AG's current Volatility is 81.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oculis Holding AG stock overvalued right now?
Oculis Holding AG (FRA:CR5) has a current Volatility of 81.51%. The current Volatility is 81.51%. Oculis Holding AG's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Volatility calculated?
Volatility is calculated from a company's financial statements. For Oculis Holding AG (FRA:CR5), the current Volatility is 81.51% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oculis Holding AG Business Description

Address Bahnhofstrasse 20, Zug, CHE, CH-6300
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
22GF Score

Get the complete analysis for FRA:CR5

Volatility is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.55
Price